NASDAQ:MBOT - Microbot Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Microbot Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $9.64 -0.65 (-6.32 %) (As of 02/25/2020 04:00 PM ET) Add Compare Today's Range$9.10Now: $9.64▼$10.4150-Day Range$8.10MA: $10.36▼$13.1752-Week Range$4.48Now: $9.64▼$20.15Volume457,829 shsAverage Volume878,082 shsMarket Capitalization$60.59 millionP/E RatioN/ADividend YieldN/ABeta5.45 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Microbot Medical Inc, a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MBOT Previous Symbol CUSIPN/A CIK883975 Webhttp://www.microbotmedical.com/ Phone781-875-3605Debt Debt-to-Equity Ratio0.02 Current Ratio2.29 Quick Ratio2.29Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.40 per share Price / Book24.10Profitability EPS (Most Recent Fiscal Year)($2.41) Net Income$-7,240,000.00 Net MarginsN/A Return on Equity-120.41% Return on Assets-68.71%Miscellaneous Employees9 Outstanding Shares6,285,000Market Cap$60.59 million Next Earnings Date4/6/2020 (Estimated) OptionableNot Optionable Receive MBOT News and Ratings via Email Sign-up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:MBOT Rates by TradingView Microbot Medical (NASDAQ:MBOT) Frequently Asked Questions What is Microbot Medical's stock symbol? Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT." When did Microbot Medical's stock split? How did Microbot Medical's stock split work? Microbot Medical's stock reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split. How were Microbot Medical's earnings last quarter? Microbot Medical Inc (NASDAQ:MBOT) posted its quarterly earnings results on Wednesday, November, 14th. The biotechnology company reported ($0.58) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.60) by $0.02. View Microbot Medical's Earnings History. When is Microbot Medical's next earnings date? Microbot Medical is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for Microbot Medical. What price target have analysts set for MBOT? 1 analysts have issued 12-month price objectives for Microbot Medical's shares. Their forecasts range from $26.00 to $26.00. On average, they expect Microbot Medical's stock price to reach $26.00 in the next year. This suggests a possible upside of 169.7% from the stock's current price. View Analyst Price Targets for Microbot Medical. What is the consensus analysts' recommendation for Microbot Medical? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Microbot Medical. What are Wall Street analysts saying about Microbot Medical stock? Here are some recent quotes from research analysts about Microbot Medical stock: 1. According to Zacks Investment Research, "Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA. " (1/1/2020) 2. HC Wainwright analysts commented, "Our price target is derived from an estimated market value of the firm at $60M, which includes a discounted cash flow (DCF)-based asset value of SCS, assuming 60% probability of approval, 20% discount rate and 2% terminal growth rate." (9/11/2019) Has Microbot Medical been receiving favorable news coverage? Media headlines about MBOT stock have been trending very negative this week, according to InfoTrie Sentiment. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Microbot Medical earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave news coverage about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Microbot Medical. Are investors shorting Microbot Medical? Microbot Medical saw a increase in short interest in the month of January. As of January 15th, there was short interest totalling 430,700 shares, an increase of 202.2% from the December 31st total of 142,500 shares. Based on an average daily trading volume, of 1,140,000 shares, the days-to-cover ratio is presently 0.4 days. Currently, 10.1% of the company's shares are short sold. View Microbot Medical's Current Options Chain. Who are some of Microbot Medical's key competitors? Some companies that are related to Microbot Medical include ADMA Biologics (ADMA), CASI Pharmaceuticals (CASI), Brainstorm Cell Therapeutics (BCLI), LogicBio Therapeutics (LOGC), La Jolla Pharmaceutical (LJPC), Jounce Therapeutics (JNCE), Verona Pharma (TARA), Windtree Therapeutics (WINT), Solid Biosciences (SLDB), Dyadic International (DYAI), Fennec Pharmaceuticals (FENC), X4 Pharmaceuticals (XFOR), Erytech Pharma (ERYP), Gamida Cell (GMDA) and Axcella Health (AXLA). What other stocks do shareholders of Microbot Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include TransEnterix (TRXC), Advanced Micro Devices (AMD), Novavax (NVAX), Athersys (ATHX), Gilead Sciences (GILD), NVIDIA (NVDA), Sarepta Therapeutics (SRPT), NovaBay Pharmaceuticals (NBY), Micron Technology (MU) and AcelRx Pharmaceuticals (ACRX). Who are Microbot Medical's key executives? Microbot Medical's management team includes the folowing people: Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 46)Mr. David Ben Naim CPA, M.B.A., Chief Financial Officer (Age 50)Dr. Simon Sharon, CTO & Chairman of Scientific Advisory BoardProf. Moshe Shoham, Co-Founder, Scientific Director & Member of Scientific Advisory Board (Age 67)Dr. Eric C. Leuthardt, Scientific Director & Member of Scientific Advisory Board Who are Microbot Medical's major shareholders? Microbot Medical's stock is owned by a number of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (3.00%) and Virtu Financial LLC (0.95%). View Institutional Ownership Trends for Microbot Medical. Which institutional investors are selling Microbot Medical stock? MBOT stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. View Insider Buying and Selling for Microbot Medical. Which institutional investors are buying Microbot Medical stock? MBOT stock was purchased by a variety of institutional investors in the last quarter, including Virtu Financial LLC. View Insider Buying and Selling for Microbot Medical. How do I buy shares of Microbot Medical? Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Microbot Medical's stock price today? One share of MBOT stock can currently be purchased for approximately $9.64. How big of a company is Microbot Medical? Microbot Medical has a market capitalization of $60.59 million. The biotechnology company earns $-7,240,000.00 in net income (profit) each year or ($2.41) on an earnings per share basis. Microbot Medical employs 9 workers across the globe.View Additional Information About Microbot Medical. What is Microbot Medical's official website? The official website for Microbot Medical is http://www.microbotmedical.com/. How can I contact Microbot Medical? Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company can be reached via phone at 781-875-3605 or via email at [email protected] MarketBeat Community Rating for Microbot Medical (NASDAQ MBOT)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 331 (Vote Outperform)Underperform Votes: 257 (Vote Underperform)Total Votes: 588MarketBeat's community ratings are surveys of what our community members think about Microbot Medical and other stocks. Vote "Outperform" if you believe MBOT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MBOT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/25/2020 by MarketBeat.com StaffFeatured Article: What is Cost of Goods Sold (COGS)?
